Table 2.
Table 2.
Adult Attention Deficit Hyperactivity Disorder (ADHD) Toolkit Web Usage Data
| Page Views of Section Webpages | Downloads of Toolkit Resources | ||
|---|---|---|---|
| Section | n (%) | Resource | n (%) |
| Toolkit Home Page | 186 (47.2) | Adult ADHD Assessment and Diagnosis Approach Algorithm | 30 (19.0) |
| ADHD Screeners & Quality of Life Assessments | 23 (14.6) | ||
| Section 2: Adult ADHD Assessment & Diagnosis | 72 (18.3) | Patient Handout: Managing Adult ADHD | 14 (8.9) |
| FDA Approved Stimulant Medications for Adult ADHD | 11 (7.0) | ||
| Physician Handout: Adult ADHD Treatment | 11 (7.0) | ||
| Section 3: Treatment and Management of ADHD in Adults | 52 (13.2) | Current Behavior Scale - Partner Report | 11 (7.0) |
| DSM-5 Diagnostic Criteria for ADHD | 9 (5.7) | ||
| Overview of Treatment Recommendations for Adult ADHD | 9 (5.7) | ||
| Section 1: About Adult ADHD | 40 (10.2) | Overview of Possible Causes for Presenting Symptoms Similar to ADHD | 8 (5.1) |
| Differential Diagnosis of ADHD in Adults | 7 (4.4) | ||
| Child Behavior Scale - Parent Report | 6 (3.8) | ||
| Section 4: Risk Reduction | 15 (3.8) | Symptoms of ADHD in Adults | 4 (2.5) |
| FDA Approved Non-Stimulant Medications for Adult ADHD | 3 (1.9) | ||
| Section 5: Adult ADHD in Specific Patient Groups | 15 (3.8) | National Resource Center on ADHD (CHADD): Diagnosis of ADHD in Adults* | 3 (1.9) |
| ADHD Risk Reduction Checklist | 3 (1.9) | ||
| Section 6: FAQ | 13 (3.3) | Adverse Effects of Selected Medications used in the Treatment of ADHD in Adults | 3 (1.9) |
| Physician Handout: Adult ADHD Overview | 1 (0.6) | ||
| Acknowledgments | 1 (0.3) | Interventions for Minimizing Drug Misuse based on Patient Risk | 1 (0.6) |
| Universal precautions to reduce stimulant misuse in treating adult ADHD* | 1 (0.6) | ||
| Total | 394 | Total | 158 |
↵* Non-AAFP, external document used with permission; Date Range: 11/1/2019 - 3/31/2020.
FDA, Food and Drug Administration; FAQ, Frequently Asked Questions.
